SUNNYVALE, Calif., Jan. 11, 2018 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today the appointment of
Beverly A. Huss to the company's
Board of Directors, effective January 7,
2018. Ms. Huss also currently serves on the boards of Qool
Therapeutics, Inc., Surefire Medical, Inc., and Madorra. Her prior
public company board experience includes Artes Medical, Wright
Medical Group, and Dade Behring, Inc.
Ms. Huss is an accomplished chief executive officer who brings
more than 22 years of management experience in the medical device
industry. Since 2013 she has served as president and chief
executive officer of Qool Therapeutics, formerly Thermocure, Inc.,
a development stage company focused on creating a novel
non-invasive device for the preservation of tissue following a
heart attack, stroke, traumatic brain injury and other medical
conditions. Prior to joining Qool, Ms. Huss was President and Chief
Executive Officer at start-up medical device company Vibrynt, Inc.,
and held multiple senior level leadership positions at Guidant
Corporation, including, most recently President, Endovascular
Solutions, and Vice President, Global Marketing, Vascular
Intervention and Vice President of the Stent Business Unit.
"We are extremely pleased to welcome Beverly Huss to the Accuray Board of Directors.
Beverly has a strong reputation in the medical device industry as a
very effective leader with a track record for achieving operational
excellence resulting in business growth. The combination of her
business leadership and public company governance experience,
across both large and small companies, make her an ideal choice to
join our board," said Joshua H.
Levine, President and Chief Executive Officer.
"I'm thrilled to have the opportunity to join Accuray's Board of
Directors and be a part of a company that is using its innovative,
industry-leading technologies to provide real hope to cancer
patients and their families. The commitment and passion shared by
the global Accuray team is inspiring," said Beverly Huss.
With the appointment of Ms. Huss, Accuray's Board consists of
seven members.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is a radiation oncology company
that develops, manufactures, and sells precise, innovative tumor
treatment solutions that set the standard of care with the aim of
helping patients live longer, better lives. The company's
leading-edge technologies deliver the full range of radiation
therapy and radiosurgery treatments. For more information, please
visit www.accuray.com.
Investor Contact:
Doug Sherk
EVC Group
+1 (646) 445-4800
dsherk@evcgroup.com
Media Contact:
Beth Kaplan
Accuray
+1 (408)
789-4426
bkaplan@accuray.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/beverly-a-huss-joins-accuray-board-of-directors-300581654.html
SOURCE Accuray Incorporated